- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 351
FTC calls foul on DraftKings/FanDuel merger
The US Federal Trade Commission has joined two US states to seek an injunction blocking the merger of the corporate-backed daily fantasy sports companies.
Jun 21, 2017Catapult Therapy TCR hits exit
TCR, a joint venture involving Imperial Innovations and UCL Business, has been acquired by Cell Medica, itself backed by Touchstone Innovations.
Jun 20, 2017Recruit takes TrustYou in acquisition deal
Recruit has acqured Ganske Verlagsgruppe and HP Autonomy-backed consumer feedback platform TrustYou for an undisclosed amount.
Jun 20, 2017Big Deal: Walmart's buys Bonobos for $310m
Coppel and Nordstrom-backed Bonobos has become the latest online retailer to be bought as part of Walmart's e-commerce growth strategy, in what could be a hugely-sized acqui-hire.
Jun 19, 2017Amazon approaches Slack for $9bn acquisition
Amazon has reportedly made overtures to the messaging platform over an acquisition that would give hefty exits to GV and Comcast Ventures.
Jun 15, 2017Wanderful finds path to acquisition
OwnLocal has acquired Wanderful Media, an advertising technology developer that had raised a total of more than $50m from 12 media companies.
Jun 12, 2017WeWork spies FieldLens for acquisition
SoftBank has exited field management app developer FieldLens after WeWork paid an undisclosed sum to acquire the company.
Jun 9, 2017Shotspotter shoots to IPO
The gunfire detection technology provider floated in the middle of its range in a $30.8m IPO that gave an exit to Motorola Solutions Venture Capital.
Jun 8, 2017Lonza captures PharmaCell
PharmaCell, a spinout of Brightlands Maastricht Health Campus, has been acquired by Lonza.
Jun 8, 2017Aileron to align itself with public markets
Stapled peptide developer Aileron Therapeutics has filed for a $69m IPO that will allow Roche, Novartis, GlaxoSmithKline and Eli Lilly to exit.
Jun 7, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


